KRISTI CATACUTAN: Open Payments
NPI 1780239210 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,186 in 63 payments from 19 companies in 2025. Trend: 2023 $87 · 2024 $123 · 2025 $1,186
Food & beverage: $1,186
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $178 |
| AstraZeneca Pharmaceuticals LP | 10 | $152 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $135 |
| Novo Nordisk Inc | 5 | $113 |
| Lilly USA, LLC | 3 | $62 |
| Exact Sciences Corporation | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| ABBVIE INC. | 3 | $49 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $40 |
Products named: JARDIANCE, Kerendia, TRELEGY ELLIPTA, Ozempic, AIRSUPRA, BREZTRI, FARXIGA, Rybelsus.
Industry payments across TX — which companies pay providers there.
